Imatinib Mesylate 220127-57-1

• Post Date:

  May 07,2019

• Expiry Date:

  Nov 03,2019

• Detailed Description:

  Cas No. :220127-57-1 A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).

• CAS Registry Number:

  220127-57-1

• Synonyms:

  ;Glivec;gleevec;imatinib methanesulfonate;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;Imatinibmesylate;Imatinib mesylate(Alpha form);

• Molecular Formula:

  C₃₀H₃₅N₇O₄S

• Molecular Weight:

  589.71

• Molecular Structure:

  

• Company:

  Shanghai Neopharm Co., Ltd.     [ China ]          

• Contact:

  Carol Zhu

• Tel:

  021-58826758

• Fax:

  021-58827258

• Email:

  sales@neopharm.com.cn